Morais, S., Antunes, L., Bento, M. J., & Lunet, N. (2017). Cumulative incidence estimates in the presence of competing risks. Journal of Clinical Epidemiology.

Pereira, S., Fontes, F., Sonin, T., Dias, T., et al. (2017). Neuropathic Pain After Breast Cancer Treatment: Characterization and Risk Factors. Journal of Pain and Symptom Management, 54(6), 877 - 888.

Pereira, S., Fontes, F., Sonin, T., Dias, T., et al. (2016). Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study. Supportive Care in Cancer, 24(4), 1571 - 1581.

Fontes, F., Pereira, S., Castro-Lopes, J. M., & Lunet, N. (2016). A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis. Breast, 29, 31 - 38.

Botelho, F., Pina, F., Silva, P., Figueiredo, G., et al. (2010). Vascular endothelial growth factor (VEGF) and prostate pathology. International Braz J Urol, 36(4), 430 - 437.

Xavier, P., Belo, L., Beires, J., Rebelo, I., et al. (2006). Serum levels of VEGF and TNF-a and their association with C-reactive protein in patients with endometriosis. Archives of Gynecology and Obstetrics, 273(4), 227 - 231.

Xavier, P., Beires, J., Belo, L., Rebelo, I., et al. (2005). Are we employing the most effective CA 125 and CA 19-9 cut-off values to detect endometriosis? [1]. European Journal of Obstetrics Gynecology and Reproductive Biology, 123(2), 254 - 255.